Arkolith/Insider Trading/AEON/Form 4

Grodnensky Oleg

10% OwnerAEON Biopharma, Inc. (AEON) · full profile →Form 4 · filed Jul 26, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
11
2 non-derivative · 9 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 21, 2023Conversion(C)6.9M——6.9M
Jul 21, 2023Conversion(C)89K——7.0M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 21, 2023Conversion(C)6.9M——0
Jul 21, 2023Grant(A)5.3M——0
Jul 21, 2023Conversion(C)39K——39K
Jul 21, 2023Conversion(C)39K——39K
Jul 21, 2023Conversion(C)21K——21K
Jul 21, 2023Conversion(C)20K——20K
Jul 21, 2023Conversion(C)22K——22K
Jul 21, 2023Conversion(C)8K——8K
Jul 21, 2023Conversion(C)77K——77K

Transaction Codes

C
Conversion of a derivative
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950103-23-010810) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for AEON Biopharma, Inc.

Build

Ask your agent about AEON insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Get a key Compare plansForm 4 data
Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0000950103-23-010810"
Ask your agent
Use Arkolith to summarize insider buying and selling at AEON Biopharma, Inc.
over the last 90 days and cite the filings.